Ivermectin binds importin

Stable Identifier
R-HSA-9924266
Type
Reaction [transition]
Species
Homo sapiens
Compartment
cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Ivermectin binds importin
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Ivermectin is a macrocyclic drug that is approved against onchocerciasis and other parasitic diseases. It binds the alpha subunit of the importin heterodimer (IMPα/β1). This binding, characterized in vitro using recombinant mouse importins, leads to the dissociation of the IMPα/β1 heterodimer and prevents IMPα from binding to IMPβ1. As a result, ivermectin blocks nuclear import, specifically of host and viral proteins that have a classical nuclear localization signal (cNLS) motif (Yang et al., 2020; reviewed in Jans & Wagstaff, 2020).
Literature References
PubMed ID Title Journal Year
32942671 Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?

Jans, DA, Wagstaff, KM

Cells 2020
32135219 The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer

Yang, SNY, Atkinson, SC, Wang, C, Lee, A, Bogoyevitch, MA, Borg, NA, Jans, DA

Antiviral Res 2020
Participants
Input
Output
Participates
as an event of
Inferred From
Ivermectin binds importin (Mus musculus)
Authored
Stephan, R  (2024-10-09)
Reviewed
Mansur, DS  (2025-09-18)
Roque Ascenção, F  (2025-10-29)
Created
Stephan, R  (2024-10-11)
Cite Us!